Company profile

Nasdaq: SLAB

SILICON LABORATORIES INC.

SILICON LABORATORIES INC. (SLAB) is a U.S. SEC registrant. The Commission classifies the issuer under SIC 3674 (Semiconductors & Related Devices).

CIK
0001038074
Research Profile
Developing · 71
Coverage
Universe
Profile updated
Aug 17, 2026
Business
Semiconductors & Related Devices
Exchange / ticker
Nasdaq: SLAB
Industry
Technology
Headquarters
United States
Latest revenue
$228.2M
Latest filing
10-Q · Aug 11, 2026
Coverage status
Universe only
Taxonomy
US-GAAP

Company overview

What does SILICON LABORATORIES INC. do?

SILICON LABORATORIES INC. (SLAB) is a U.S. SEC registrant. The Commission classifies the issuer under SIC 3674 (Semiconductors & Related Devices).

What does SILICON LABORATORIES INC. do?

SILICON LABORATORIES INC. (SLAB) is a U.S. SEC registrant. The Commission classifies the issuer under SIC 3674 (Semiconductors & Related Devices).

What industry is SILICON LABORATORIES INC. in?

Technology · Semiconductors & Related Devices

What was SILICON LABORATORIES INC.'s latest reported revenue?

$228.2M for Q3 2026, from 10-Q filed Aug 11, 2026.

What changed in the latest comparable period?

Revenue increased +18.3% ($192.8M to $228.2M; Q3 2025 vs Q3 2026).

Business model (from the public record)

Belvedere describes the business using the issuer’s SEC classification and the company description extracted from public filings. Segment mix, customer identity, and recurring-versus-transactional revenue are shown only when those facts are identified in the filing extract—not inferred.

Technology · Semiconductors & Related Devices · United States

Financial profile

Revenue
$228.2M
10-Q · Q3 2026 · Filed Aug 11, 2026
Revenue growth YoY
+18.3%
Belvedere calculation · 10-Q · Q3 2026 · Filed Aug 11, 2026
Gross margin
+61.6%
Belvedere calculation · 10-Q · Q3 2026 · Filed Aug 11, 2026
Operating margin
-4.7%
Belvedere calculation · 10-Q · Q3 2026 · Filed Aug 11, 2026
Net income
-$10.6M
10-Q · Q3 2026 · Filed Aug 11, 2026
Operating cash flow
Not identified in latest matched XBRL period
Capex
Not identified in latest matched XBRL period
Belvedere FCF
Not identified in latest matched XBRL period
FCF margin
Not identified in latest matched XBRL period
Cash
$362.2M
10-Q · Jul 4, 2026 · Filed Aug 11, 2026
Debt
Not identified in latest matched XBRL period
Net debt
-$362.2M
Belvedere calculation · 10-Q · Jul 4, 2026 · Filed Aug 11, 2026
Shares
33,366,000
10-Q · Jul 4, 2026 · Filed Aug 11, 2026

Balance sheet snapshot

Cash $362.2M. Identified debt . Net debt -$362.2M. Missing debt tags are not treated as a zero-debt capital structure.

Financial information is derived from public filings and other identified sources. Belvedere calculations may differ from company-defined non-GAAP measures. See methodology and source notes. Valuation multiples are omitted because a licensed market-data provider is not configured.

Latest filings

FormFiledPeriodAccessionSource
10-QAug 11, 2026Jul 4, 20260001038074-26-000029SEC
8-KAug 11, 2026Aug 11, 20260001038074-26-000027SEC
8-KMay 26, 2026May 22, 20260001193125-26-237879SEC
10-QMay 5, 2026Apr 4, 20260001038074-26-000020SEC
8-KMay 5, 2026May 5, 20260001038074-26-000018SEC
8-KApr 30, 2026Apr 30, 20260001038074-26-000014SEC
8-KApr 24, 2026Apr 23, 20260001038074-26-000012SEC
DEF 14AMar 11, 2026Apr 23, 20260001193125-26-102113SEC

What changed

Revenue+18.3%Revenue increased +18.3% ($192.8M to $228.2M; Q3 2025 vs Q3 2026).
Revenue growth acceleration$0.18Quarterly revenue YoY growth moved from +20.1% to +18.3% (-1.8 percentage points).
Gross margin$0.62Reported gross margin was +61.6% in the latest comparable period.
Cash$362.2MCash and cash equivalents were $362.2M as of the latest reported balance-sheet date.
Shares outstanding$33.4MShares outstanding were 33,366,000 as of the latest reported date.

Each line is an arithmetic comparison of sourced facts. It is not a thesis.

Research view

Belvedere has not published an initiation or update on SILICON LABORATORIES INC.. Universe inclusion is not a rating, a forecast, or coverage in the sell-side sense.

Research Radar

KindChangeExplanationSourceDate
Revenue+18.3%Revenue increased +18.3% ($192.8M to $228.2M; Q3 2025 vs Q3 2026).10-Q · RevenueFromContractWithCustomerExcludingAssessedTaxAug 11, 2026
Revenue acceleration-1.8 ppQuarterly revenue YoY growth moved from +20.1% to +18.3% (-1.8 percentage points).10-Q · BelvedereRevenueGrowthYoYAug 11, 2026
Margin change$0.616Reported gross margin was +61.6% in the latest comparable period.10-Q · BelvedereGrossMarginAug 11, 2026
Cash$362.2MCash and cash equivalents were $362.2M as of the latest reported balance-sheet date.10-Q · CashAndCashEquivalentsAtCarryingValueAug 11, 2026
Share count$33.4MShares outstanding were 33,366,000 as of the latest reported date.10-Q · CommonStockSharesOutstandingAug 11, 2026

Open the full Research Radar

Rankings

Industry context

SILICON LABORATORIES INC. is mapped to Technology (Semiconductors & Related Devices) from SIC metadata on the SEC submission. Mapping is a classification convenience, not a claim that every peer is economically comparable.

Belvedere Research Profile

DevelopingResearch Profile Index 71

This measures researchable information characteristics. It is not investment advice, a credit rating, or a buy/sell/hold recommendation.

Financial Disclosure79

Presence of core income-statement, cash-flow and balance-sheet concepts in SEC XBRL.

Operating Visibility100

Comparable-period revenue history and operating-result availability.

KPI Transparency70

Availability of margin, cash-flow and per-share concepts used in screening.

Investor Information60

SEC periodic reports, current reports, proxy statement and website identified in submissions.

Financial History47

Distinct filing years in the current archive window plus comparable prior-period revenue.

Research Profile methodology

Risks

Belvedere does not manufacture generic risk language. Material risks are those the issuer discloses in its periodic reports, particularly Item 1A of the latest Form 10-K.

A Form 10-K was not present in the current filing window.

Sources

Revenue: $228.2M
Source
U.S. Securities and Exchange Commission
Form
10-Q
Period
Q3 2026
Filed
Aug 11, 2026
Accession
0001038074-26-000029
Concept
RevenueFromContractWithCustomerExcludingAssessedTax
View filing
Revenue growth (Belvedere calculation)
Source
U.S. Securities and Exchange Commission
Form
10-Q
Period
Q3 2026
Filed
Aug 11, 2026
Accession
0001038074-26-000029
Concept
BelvedereRevenueGrowthYoY

(RevenueFromContractWithCustomerExcludingAssessedTax 2026-07-04 / RevenueFromContractWithCustomerExcludingAssessedTax 2025-07-05) - 1

View filing
Cash
Source
U.S. Securities and Exchange Commission
Form
10-Q
Period
Jul 4, 2026
Filed
Aug 11, 2026
Accession
0001038074-26-000029
Concept
CashAndCashEquivalentsAtCarryingValue
View filing

Disclosure

Belvedere Research publishes informational analysis. Nothing on this site is investment advice, an offer, or a solicitation to buy or sell any security.

This page is a company intelligence / data profile. It is not a research report unless a dated note is attached above. Rankings appearing here are independent of any issuer compensation.

Frequently asked questions

What does SILICON LABORATORIES INC. do?
SILICON LABORATORIES INC. (SLAB) is a U.S. SEC registrant. The Commission classifies the issuer under SIC 3674 (Semiconductors & Related Devices).
What industry is SILICON LABORATORIES INC. in?
SILICON LABORATORIES INC. is classified in Technology (Semiconductors & Related Devices).
When did SILICON LABORATORIES INC. last file a periodic report?
SILICON LABORATORIES INC. last filed a 10-Q on Aug 11, 2026 (accession 0001038074-26-000029).
What was SILICON LABORATORIES INC.'s latest revenue?
$228.2M for Q3 2026, sourced from 10-Q filed Aug 11, 2026.
Does Belvedere cover SILICON LABORATORIES INC.?
SILICON LABORATORIES INC. is in the Belvedere universe. Presence in the universe is not the same as active initiation coverage.